All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-0320ZP1753 | Anti-PTPN13 (BD32) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | BD32 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1754 | Anti-PTPN13 (BD32) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | BD32 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1755 | Anti-PTPN13 (CBYC-P779) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYC-P779 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1756 | Anti-PTPN13 (CBYC-P779) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | CBYC-P779 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1757 | Anti-PTPN13 (D6D1H) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | D6D1H | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1758 | Anti-PTPN13 (D6D1H) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | D6D1H | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1759 | Anti-PTPN13 (4F6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 4F6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1760 | Anti-PTPN13 (4F6) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 4F6 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1761 | Anti-PTPN13 (1A6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1A6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP1762 | Anti-PTPN13 (1A6) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 1A6 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION